Selected research
Industry Research
Solifenacin Succinate Drug Industry Research Report 2026
Market perspective
The global Solifenacin Succinate Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Solifenacin Succinate Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Solifenacin Succinate Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Solifenacin Succinate Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Solifenacin Succinate Drug include Teva, Qilu Pharmaceutical, Jiangxi Boya Seehot Pharmaceutical, Astellas Pharma, VESICARE, Glenmark Pharmaceuticals, Crescent Pharma, Cipla and Aurobindo Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Solifenacin Succinate Drug market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Solifenacin Succinate Drug Market by Company
Teva
Qilu Pharmaceutical
Jiangxi Boya Seehot Pharmaceutical
Astellas Pharma
VESICARE
Glenmark Pharmaceuticals
Crescent Pharma
Cipla
Aurobindo Pharma
Ajanta Pharma
Solifenacin Succinate Drug Segment by Type
5 mg Tablet
10 mg Tablet
Solifenacin Succinate Drug Segment by Application
Hospital
Drug store
Solifenacin Succinate Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Solifenacin Succinate Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Solifenacin Succinate Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Solifenacin Succinate Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Solifenacin Succinate Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Solifenacin Succinate Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Solifenacin Succinate Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 5 mg Tablet
- 10 mg Tablet
Applications
- Hospital
- Drug store
Companies covered
- Teva
- Qilu Pharmaceutical
- Jiangxi Boya Seehot Pharmaceutical
- Astellas Pharma
- VESICARE
- Glenmark Pharmaceuticals
- Crescent Pharma
- Cipla
- Aurobindo Pharma
- Ajanta Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Solifenacin Succinate Drug Market Size (2021-2032)
- 2.2.2 Global Solifenacin Succinate Drug Sales (2021-2032)
- 2.2.3 Global Solifenacin Succinate Drug Market Average Price (2021-2032)
- 2.3 Solifenacin Succinate Drug by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 5 mg Tablet
- 2.3.3 10 mg Tablet
- 2.4 Solifenacin Succinate Drug by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Drug store
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Solifenacin Succinate Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Solifenacin Succinate Drug Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Solifenacin Succinate Drug Revenue of Manufacturers (2021-2026)
- 3.4 Global Solifenacin Succinate Drug Average Price by Manufacturers (2021-2026)
- 3.5 Global Solifenacin Succinate Drug Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Solifenacin Succinate Drug, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Solifenacin Succinate Drug, Product Type & Application
- 3.8 Global Manufacturers of Solifenacin Succinate Drug, Established Date
- 3.9 Global Solifenacin Succinate Drug Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva
- 4.1.1 Teva Company Information
- 4.1.2 Teva Business Overview
- 4.1.3 Teva Solifenacin Succinate Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Solifenacin Succinate Drug Product Portfolio
- 4.1.5 Teva Recent Developments
- 4.2 Qilu Pharmaceutical
- 4.2.1 Qilu Pharmaceutical Company Information
- 4.2.2 Qilu Pharmaceutical Business Overview
- 4.2.3 Qilu Pharmaceutical Solifenacin Succinate Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Qilu Pharmaceutical Solifenacin Succinate Drug Product Portfolio
- 4.2.5 Qilu Pharmaceutical Recent Developments
- 4.3 Jiangxi Boya Seehot Pharmaceutical
- 4.3.1 Jiangxi Boya Seehot Pharmaceutical Company Information
- 4.3.2 Jiangxi Boya Seehot Pharmaceutical Business Overview
- 4.3.3 Jiangxi Boya Seehot Pharmaceutical Solifenacin Succinate Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Jiangxi Boya Seehot Pharmaceutical Solifenacin Succinate Drug Product Portfolio
- 4.3.5 Jiangxi Boya Seehot Pharmaceutical Recent Developments
- 4.4 Astellas Pharma
- 4.4.1 Astellas Pharma Company Information
- 4.4.2 Astellas Pharma Business Overview
- 4.4.3 Astellas Pharma Solifenacin Succinate Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Astellas Pharma Solifenacin Succinate Drug Product Portfolio
- 4.4.5 Astellas Pharma Recent Developments
- 4.5 VESICARE
- 4.5.1 VESICARE Company Information
- 4.5.2 VESICARE Business Overview
- 4.5.3 VESICARE Solifenacin Succinate Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 VESICARE Solifenacin Succinate Drug Product Portfolio
- 4.5.5 VESICARE Recent Developments
- 4.6 Glenmark Pharmaceuticals
- 4.6.1 Glenmark Pharmaceuticals Company Information
- 4.6.2 Glenmark Pharmaceuticals Business Overview
- 4.6.3 Glenmark Pharmaceuticals Solifenacin Succinate Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Glenmark Pharmaceuticals Solifenacin Succinate Drug Product Portfolio
- 4.6.5 Glenmark Pharmaceuticals Recent Developments
- 4.7 Crescent Pharma
- 4.7.1 Crescent Pharma Company Information
- 4.7.2 Crescent Pharma Business Overview
- 4.7.3 Crescent Pharma Solifenacin Succinate Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Crescent Pharma Solifenacin Succinate Drug Product Portfolio
- 4.7.5 Crescent Pharma Recent Developments
- 4.8 Cipla
- 4.8.1 Cipla Company Information
- 4.8.2 Cipla Business Overview
- 4.8.3 Cipla Solifenacin Succinate Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Cipla Solifenacin Succinate Drug Product Portfolio
- 4.8.5 Cipla Recent Developments
- 4.9 Aurobindo Pharma
- 4.9.1 Aurobindo Pharma Company Information
- 4.9.2 Aurobindo Pharma Business Overview
- 4.9.3 Aurobindo Pharma Solifenacin Succinate Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Aurobindo Pharma Solifenacin Succinate Drug Product Portfolio
- 4.9.5 Aurobindo Pharma Recent Developments
- 4.10 Ajanta Pharma
- 4.10.1 Ajanta Pharma Company Information
- 4.10.2 Ajanta Pharma Business Overview
- 4.10.3 Ajanta Pharma Solifenacin Succinate Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Ajanta Pharma Solifenacin Succinate Drug Product Portfolio
- 4.10.5 Ajanta Pharma Recent Developments
5 Global Solifenacin Succinate Drug Market Scenario by Region
- 5.1 Global Solifenacin Succinate Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Solifenacin Succinate Drug Sales by Region: 2021-2032
- 5.2.1 Global Solifenacin Succinate Drug Sales by Region: 2021-2026
- 5.2.2 Global Solifenacin Succinate Drug Sales by Region: 2027-2032
- 5.3 Global Solifenacin Succinate Drug Revenue by Region: 2021-2032
- 5.3.1 Global Solifenacin Succinate Drug Revenue by Region: 2021-2026
- 5.3.2 Global Solifenacin Succinate Drug Revenue by Region: 2027-2032
- 5.4 North America Solifenacin Succinate Drug Market Facts & Figures by Country
- 5.4.1 North America Solifenacin Succinate Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Solifenacin Succinate Drug Sales by Country (2021-2032)
- 5.4.3 North America Solifenacin Succinate Drug Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Solifenacin Succinate Drug Market Facts & Figures by Country
- 5.5.1 Europe Solifenacin Succinate Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Solifenacin Succinate Drug Sales by Country (2021-2032)
- 5.5.3 Europe Solifenacin Succinate Drug Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Solifenacin Succinate Drug Market Facts & Figures by Country
- 5.6.1 Asia Pacific Solifenacin Succinate Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Solifenacin Succinate Drug Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Solifenacin Succinate Drug Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Solifenacin Succinate Drug Market Facts & Figures by Country
- 5.7.1 South America Solifenacin Succinate Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Solifenacin Succinate Drug Sales by Country (2021-2032)
- 5.7.3 South America Solifenacin Succinate Drug Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Solifenacin Succinate Drug Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Solifenacin Succinate Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Solifenacin Succinate Drug Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Solifenacin Succinate Drug Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Solifenacin Succinate Drug Sales by Type (2021-2032)
- 6.1.1 Global Solifenacin Succinate Drug Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Solifenacin Succinate Drug Sales Market Share by Type (2021-2032)
- 6.2 Global Solifenacin Succinate Drug Revenue by Type (2021-2032)
- 6.2.1 Global Solifenacin Succinate Drug Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Solifenacin Succinate Drug Revenue Market Share by Type (2021-2032)
- 6.3 Global Solifenacin Succinate Drug Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Solifenacin Succinate Drug Sales by Application (2021-2032)
- 7.1.1 Global Solifenacin Succinate Drug Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Solifenacin Succinate Drug Sales Market Share by Application (2021-2032)
- 7.2 Global Solifenacin Succinate Drug Revenue by Application (2021-2032)
- 7.2.1 Global Solifenacin Succinate Drug Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Solifenacin Succinate Drug Revenue Market Share by Application (2021-2032)
- 7.3 Global Solifenacin Succinate Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Solifenacin Succinate Drug Value Chain Analysis
- 8.1.1 Solifenacin Succinate Drug Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Solifenacin Succinate Drug Production Mode & Process
- 8.2 Solifenacin Succinate Drug Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Solifenacin Succinate Drug Distributors
- 8.2.3 Solifenacin Succinate Drug Customers
9 Global Solifenacin Succinate Drug Analyzing Market Dynamics
- 9.1 Solifenacin Succinate Drug Industry Trends
- 9.2 Solifenacin Succinate Drug Industry Drivers
- 9.3 Solifenacin Succinate Drug Industry Opportunities and Challenges
- 9.4 Solifenacin Succinate Drug Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst